Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger S Lo

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Cancer Discovery|July 1, 2024
Expression of Concern: Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
The Journal of Investigative Dermatology|August 17, 2012
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinomaAmaya Viros, Robert Hayward, Matthew Martin, et al.
Analytical Chemistry|January 31, 2018
High-Speed Live-Cell Interferometry: A New Method for Quantifying Tumor Drug Resistance and HeterogeneityDian Huang, Kevin A Leslie, Daniel Guest, et al.
Molecular Cancer Therapeutics|September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicineJames S Wilmott, Varsha Tembe, Julie R Howle, et al.
Journal for Immunotherapy of Cancer|August 17, 2019
The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, et al.
Nature|March 26, 2015
Therapy-induced tumour secretomes promote resistance and tumour progressionAnna C Obenauf, Yilong Zou, Andrew L Ji, et al.
Journal of Translational Medicine|July 4, 2015
Vemurafenib resistance reprograms melanoma cells towards glutamine dependenceJenny E Hernandez-Davies, Thai Q Tran, Michael A Reid, et al.
Cell|September 12, 2015
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi ResistanceWilly Hugo, Hubing Shi, Lu Sun, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Plos One|December 24, 2011
Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathwayMohammad Atefi, Erika von Euw, Narsis Attar, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Cancer Discovery|July 1, 2024
Expression of Concern: Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
The Journal of Investigative Dermatology|August 17, 2012
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinomaAmaya Viros, Robert Hayward, Matthew Martin, et al.
Analytical Chemistry|January 31, 2018
High-Speed Live-Cell Interferometry: A New Method for Quantifying Tumor Drug Resistance and HeterogeneityDian Huang, Kevin A Leslie, Daniel Guest, et al.
Molecular Cancer Therapeutics|September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicineJames S Wilmott, Varsha Tembe, Julie R Howle, et al.
Journal for Immunotherapy of Cancer|August 17, 2019
The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, et al.
Nature|March 26, 2015
Therapy-induced tumour secretomes promote resistance and tumour progressionAnna C Obenauf, Yilong Zou, Andrew L Ji, et al.
Journal of Translational Medicine|July 4, 2015
Vemurafenib resistance reprograms melanoma cells towards glutamine dependenceJenny E Hernandez-Davies, Thai Q Tran, Michael A Reid, et al.
Cell|September 12, 2015
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi ResistanceWilly Hugo, Hubing Shi, Lu Sun, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Plos One|December 24, 2011
Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathwayMohammad Atefi, Erika von Euw, Narsis Attar, et al.
Pageof 9